From Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma:

illustration-of-larynx-trachea-bronchi-picture-id524386430

illustration-of-larynx-trachea-bronchi-picture-id524386430—

Image: iStock/yodiyim
https://www.istockphoto.com/portfolio/yodiyim?assettype=image&mediatype=photography&sort=best

Underwriters and Partners

Xconomy Insight

Sponsored · Webinar
Nov. 12 – High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Eurofins DiscoverX

Sponsored · Webinar
Oct. 28 – Accelerating COVID-19 Drug Discovery: Qualified Assays for Proinflammatory Cytokines
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
Eurofins DiscoverX

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!